Barriers and facilitators to engagement in HIV clinical care in the Deep South: results from semi-structured patient interviews.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMC 2975042)

Published in J Assoc Nurses AIDS Care on August 05, 2010

Authors

Deborah J Konkle-Parker1, K Rivet Amico, Harold M Henderson

Author Affiliations

1: Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Articles citing this

Using the HIV surveillance system to monitor the National HIV/AIDS Strategy. Am J Public Health (2012) 1.27

Accuracy of definitions for linkage to care in persons living with HIV. J Acquir Immune Defic Syndr (2013) 1.02

Barriers and facilitators to patient retention in HIV care. BMC Infect Dis (2015) 0.96

Pilot testing of an HIV medication adherence intervention in a public clinic in the Deep South. J Am Acad Nurse Pract (2012) 0.95

Qualitative to assessment of barriers and facilitators to HIV treatment. J Assoc Nurses AIDS Care (2011) 0.92

How can we facilitate entry into and retention in HIV care? HIV Clin (2010) 0.88

Understanding HIV care delays in the US South and the role of the social-level in HIV care engagement/retention: a qualitative study. Int J Equity Health (2014) 0.88

Enhanced Collection of Laboratory Data in HIV Surveillance Among 5 States with Confidential Name-based HIV Infection Reporting, 2005-2006. Open AIDS J (2012) 0.78

Effects of an intervention addressing information, motivation, and behavioral skills on HIV care adherence in a southern clinic cohort. AIDS Care (2013) 0.78

Keeping patients in care: a critical component in controlling HIV. HIV Clin (2012) 0.75

Transportation-related barriers to care among African American women living with HIV/AIDS: "What you getting out of the cab for?" Online J Rural Urban Res (2015) 0.75

Psychiatric Symptoms and Barriers to Care in HIV-Infected Individuals Who Are Lost to Care. J Int Assoc Provid AIDS Care (2017) 0.75

Articles cited by this

Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66

HIV Infection and AIDS in the Deep South. Am J Public Health (2006) 2.46

Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS (2006) 2.30

Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care (1998) 2.25

"Getting me back on track": the role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDS (2007) 2.09

Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J (2006) 1.88

Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther (2007) 1.83

Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S. AIDS Care (2006) 1.76

Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDS (2007) 1.64

Delayed access to HIV diagnosis and care: Special concerns for the Southern United States. AIDS Care (2006) 1.52

Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Natl Med Assoc (1999) 1.51

Overview: HIV/AIDS in the deep south region of the United States. AIDS Care (2006) 1.45

Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care (2008) 1.44

Religious beliefs, practices and treatment adherence among individuals with HIV in the southern United States. AIDS Patient Care STDS (2006) 1.34

Increasing AIDS case reports in the South: U.S. trends from 1981-2004. AIDS Care (2006) 1.15

Perception of racial barriers to health care in the rural South. J Health Care Poor Underserved (2006) 1.12

Differences in access to outpatient medical care for black and white adults in the rural South. Med Care (2006) 1.02

Articles by these authors

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17

Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04

An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol (2006) 4.22

The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis (2013) 4.04

Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr (2012) 2.74

Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep (2008) 2.30

HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav (2013) 2.07

Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep (2010) 2.02

The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep (2008) 1.83

Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative Research, Acceptability, and Fidelity of the Options Project. J Acquir Immune Defic Syndr (2004) 1.80

Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model. Health Psychol (2006) 1.52

A proposal for quality standards for measuring medication adherence in research. AIDS Behav (2013) 1.51

Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav (2011) 1.49

Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc (2013) 1.47

Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care (2008) 1.44

Understanding the behavioral determinants of retention in HIV care: a qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDS (2012) 1.34

Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS (2015) 1.30

Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care (2012) 1.26

Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS (2004) 1.23

The relationship-oriented information-motivation-behavioral skills model: a multilevel structural equation model among dyads. AIDS Behav (2008) 1.20

Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care STDS (2013) 1.14

Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav (2012) 1.07

An agenda for advancing the science of implementation of evidence-based HIV prevention interventions. AIDS Behav (2009) 1.06

Feasibility, acceptability and preliminary efficacy of an online peer-to-peer social support ART adherence intervention. AIDS Behav (2013) 1.06

HIV drug resistance and HIV transmission risk behaviors among active injection drug users. J Acquir Immune Defic Syndr (2005) 1.05

Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. J Int Assoc Provid AIDS Care (2013) 1.04

Development and pilot testing of a standardized training program for a patient-mentoring intervention to increase adherence to outpatient HIV care. AIDS Patient Care STDS (2012) 1.03

Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr (2014) 1.00

Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial. AIDS Behav (2014) 1.00

Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial. AIDS Behav (2015) 0.98

Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care STDS (2014) 0.97

Parental information, motivation, and behavioral skills correlate with child sweetened beverage consumption. J Nutr Educ Behav (2011) 0.93

HIV prevention counseling intervention delivered during routine clinical care reduces HIV risk behavior in HIV-infected South Africans receiving antiretroviral therapy: the Izindlela Zokuphila/Options for Health randomized trial. J Acquir Immune Defic Syndr (2014) 0.93

Counsellor-delivered HIV risk reduction intervention addresses safer sex barriers of people living with HIV in KwaZulu-Natal, South Africa. Psychol Health (2011) 0.93

Qualitative to assessment of barriers and facilitators to HIV treatment. J Assoc Nurses AIDS Care (2011) 0.92

Engagement in HIV Medical Care and Technology Use among Stimulant-Using and Nonstimulant-Using Men who have Sex with Men. AIDS Res Treat (2013) 0.91

Standard of care: promoting antiretroviral adherence in clinical care. AIDS Care (2005) 0.91

A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care. MedGenMed (2006) 0.91

Information, motivation, and behavioral skills for early pre-ART engagement in HIV care among patients entering clinical care in KwaZulu-Natal, South Africa. AIDS Care (2013) 0.90

Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia. AIDS Care (2012) 0.89

Information-motivation-behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among HIV+ patients in clinical care. AIDS Care (2010) 0.88

Antiretroviral Therapy Adherence Enhancing Interventions for Adolescents and Young Adults 13-24 Years of Age: A Review of the Evidence Base. J Acquir Immune Defic Syndr (2016) 0.87

An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care (2013) 0.86

Prevention needs of HIV-positive men and women awaiting release from prison. AIDS Behav (2012) 0.84

Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia. AIDS Care (2013) 0.84

Pilot test of an emotional education intervention component for sexual risk reduction. Health Psychol (2011) 0.84

Relative efficacy of a pregnancy, sexually transmitted infection, or human immunodeficiency virus prevention-focused intervention on changing sexual risk behavior among young adults. J Am Coll Health (2012) 0.81

Accuracy of the stages of change algorithm: sexual risk reported in the maintenance stage of change. Prev Sci (2008) 0.78

Effects of an intervention addressing information, motivation, and behavioral skills on HIV care adherence in a southern clinic cohort. AIDS Care (2013) 0.78

Development and Implementation of a Culturally Tailored Diabetes Intervention in Primary Care. Transl Behav Med (2011) 0.77

Endocrine aspects in patients infected with the human immunodeficiency virus. J Miss State Med Assoc (2012) 0.76

The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the science and implications for the Asia-Pacific region. Sex Health (2014) 0.75

Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care. AIDS Care (2008) 0.75

SEXUAL PRACTICES AMONG MEN WHO HAVE SEX WITH MEN IN CHIANG MAI, THAILAND: PART OF THE ANTIRETROVIRAL PRE-EXPOSURE PROPHYLAXIS TRIAL. Southeast Asian J Trop Med Public Health (2016) 0.75

Bedaquiline adherence measured by electronic dose monitoring predicts clinical outcomes in the treatment of patients with multidrug-resistant tuberculosis and HIV/AIDS. J Acquir Immune Defic Syndr (2022) 0.75